Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.

Wenyin ShiDeborah T BlumenthalNancy Ann Oberheim BushSied KebirRimas V LukasYoshihiro MuragakiJay-Jiguang ZhuMartin Glas

Published in: Journal of neuro-oncology (2020)

This TTFields safety surveillance analysis in > 11,000 patients revealed no new safety concerns, with a favorable safety profile comparable with published TTFields/GBM trials. The safety profile remained consistent among subgroups, suggesting feasibility in multiple populations, including elderly patients.

Keyphrases

high grade
clinical practice
end stage renal disease
chronic kidney disease
ejection fraction
prognostic factors
data analysis